text: 27154406_12	EEAO treatment, however, significantly reduced emphysema and inflammatory cell infiltration to the lung with concomitant decrease of the production of pro-inflammatory cytokines including TNF-a, IL-6, and TGF-b, signature cytokines of COPD.